Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,546 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06424275 | Prostate Cancer Awareness and Initiative for Screening in the European Union(PRAISE-U) | enrolling by invitation | — | 20,000 | European Association of Urology Research FoundationOTHER | 4 | Aug 15, 2025 | clinicaltrials |
| NCT07101900 | 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses | enrolling by invitation | Phase 2 | 100 | Peking Union Medical College HospitalOTHER |
| 1 |
| Aug 8, 2025 |
| clinicaltrials |
| NCT07091565 | Supporting Sexual Recovery in Women With Bladder Cancer(SPARC) | enrolling by invitation | — | 60 | King's College LondonOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07058753 | Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery.(PREHONED) | enrolling by invitation | N/A | 100 | Medical University of SilesiaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07046832 | Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy | enrolling by invitation | N/A | 104 | MediView XR, Inc.INDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT04165460 | Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients | enrolling by invitation | N/A | 92 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT03423303 | A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)(ProScreen) | enrolling by invitation | N/A | 17,400 | Tampere UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06223022 | Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment | enrolling by invitation | N/A | 512 | Umeå UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC)(PPPC) | enrolling by invitation | — | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06786780 | Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids(ECCO) | enrolling by invitation | Phase 2 | 50 | Chongqing University Cancer HospitalOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06505356 | Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage | enrolling by invitation | N/A | 400 | Edgaras BurzinskisOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06864572 | [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06723665 | The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients | enrolling by invitation | N/A | 50 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06780358 | Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02(RAISE02) | enrolling by invitation | N/A | 64 | CystotechINDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06760689 | Brief Title- Virtual Reality Glasses in Gynecologic Cancer | enrolling by invitation | N/A | 118 | Çankırı Karatekin UniversityOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06755515 | A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | enrolling by invitation | Phase 2 / Phase 3 | 510 | Shandong New Time Pharmaceutical Co., LTDINDUSTRY | 1 | Jan 1, 2025 | clinicaltrials |
| NCT06583395 | Quest to Analyze One Thousand Humans Meditating(QUANTUM) | enrolling by invitation | — | 3,000 | Tobias Moeller-BertramINDUSTRY | 1 | Nov 1, 2024 | clinicaltrials |
| NCT03459820 | Prostate Cancer Patient Management With 18F-DCFPyL PET/CT | enrolling by invitation | Phase 2 / Phase 3 | 1,500 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT05528237 | HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals(ACCESS) | enrolling by invitation | N/A | 50 | University of WashingtonOTHER | 1 | Sep 6, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Aug 15, 2025source: clinicaltrials